Pregled bibliografske jedinice broj: 806945
Chronic obstructive pulmonary disease and comorbidities
Chronic obstructive pulmonary disease and comorbidities // 25th Annual Congress of the European Respiratory Society (ERS 2015) ; u: European Respiratory Journal 46 (2015)(S 59)
Amsterdam, Nizozemska, 2015. str. PA1123 P-PA1123 P (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 806945 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Chronic obstructive pulmonary disease and comorbidities
Autori
Sokolović, Irena ; Knežević, Jelena ; Popović-Grle, Sanja ; Vukić Dugac, Andrea ; Bubanović, Gordana ; Janković Makek, Mateja ; Hećimović, Ana ; Redžepi, Gzim ; Samaržija, Miroslav ; Jakopovic, Marko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
25th Annual Congress of the European Respiratory Society (ERS 2015) ; u: European Respiratory Journal 46 (2015)(S 59)
/ - , 2015, PA1123 P-PA1123 P
Skup
Annual Congress of the European Respiratory Society (25 ; 2015)
Mjesto i datum
Amsterdam, Nizozemska, 26.09.2015. - 30.09.2015
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Chronic obstructive lung diseases
Sažetak
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide. Although it is well known that comorbidities are highly prevalent in patients with COPD, they are not considered for treatment effect analysis. To observe frequency of comorbidities in patients with COPD and compare its distribution in 4 GOLD groups. Observational cross sectional study was designed to identify comorbidities related with categorized disease groups. Patients with COPD treated at University Hospital Centre were included. Severity of COPD was estimated and number of comorbidities was counted. Comorbidity was defined as the presence of disorder in addition to COPD irrespective of their relation to COPD. We enrolled 460 COPD patients (68, 5% males ; average age at diagnosis 61, 3 years. Majority of patients were in GOLD group A (41%) and B (29%), followed by group D (25%) and C (5%). Comorbidities were present in 90% of patients, with 31% of patients with 1 comorbidity, 31% with 2 comorbidities and 28% with 3 or more (mean of 1.9). There was no significant difference in number of comorbidities among GOLD groups (P=0.81). Most common comorbidities were arterial hypertension (47%), lung neoplasm (40%) and cardiovascular diseases (23%). We showed that COPD is rarely diagnosed as an isolated condition, since different comorbidities were present in 90% of patients. Hypertension, lung neoplasms and cardiovascular diseases were revealed as the most common ones. High proportion of lung cancer can be attributed to searching for COPD in lung cancer patients. A multidimensional COPD diagnosis approach should be taken into account when classifying COPD patients into GOLD groups.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Napomena
DOI: 10.1183/13993003.congress-2015.PA1123
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Klinika za plućne bolesti "Jordanovac",
Klinički bolnički centar Zagreb
Profili:
Ana Hećimović
(autor)
Jelena Knežević
(autor)
Irena Sokolović
(autor)
Miroslav Samaržija
(autor)
Sanja Popović-Grle
(autor)
Mateja Janković Makek
(autor)
Gordana Bubanović
(autor)
Marko Jakopović
(autor)
Gzim Redžepi
(autor)
Andrea Vukić Dugac
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE